ResearcherUniversity of UtahNo recent work listed
Laurent Dumartin
Matched on OpenAlex author ID A5002325059. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 33
2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 1 paper
Papers 7
- Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling. Co-author DOI 10.1002/1878-0261.12463↗
- ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation. Co-author DOI 10.1038/onc.2016.459↗
- Splice variants as novel targets in pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41598-017-03354-z↗
- Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-15-2864↗
- Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-14-2467↗
- A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13073-014-0105-3↗
- AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Co-author DOI 10.1158/0008-5472.can-11-1367↗
Closest collaborators
The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tatjana Crnogorac‐Jurcevic · 6 shared papers, 2011–2019 · strength 0.32
- Paper Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling. DOI 10.1002/1878-0261.12463↗
- Paper ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation. DOI 10.1038/onc.2016.459↗
- Paper Splice variants as novel targets in pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-017-03354-z↗
- Tomasz P. Radon · 4 shared papers, 2015–2019 · strength 0.26
- Paper Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling. DOI 10.1002/1878-0261.12463↗
- Paper ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation. DOI 10.1038/onc.2016.459↗
- Paper Splice variants as novel targets in pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-017-03354-z↗
- Wasfi Alrawashdeh · 3 shared papers, 2015–2019 · strength 0.20
- Paper Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling. DOI 10.1002/1878-0261.12463↗
- Paper ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation. DOI 10.1038/onc.2016.459↗
- Paper Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. DOI 10.1158/1078-0432.ccr-14-2467↗
- Jun Wang · 2 shared papers, 2014–2017 · strength 0.10
- Claude Chelala · 2 shared papers, 2014–2017 · strength 0.10
- Aldo Scarpa · 2 shared papers, 2014–2017 · strength 0.10
- İhsan Ekin Demir · 1 shared paper, 2019 · strength 0.09
- Guralp Onur Ceyhan · 1 shared paper, 2019 · strength 0.09
- Hemant Mahendrakumar Kocher · 2 shared papers, 2014–2015 · strength 0.08
- Sara Maria David Trabulo · 1 shared paper, 2017 · strength 0.06
- Marina Pasca di Magliano · 1 shared paper, 2017 · strength 0.06
- Iréne Esposito · 1 shared paper, 2017 · strength 0.06
- Christopher Heeschen · 1 shared paper, 2017 · strength 0.06
- Andrea Mafficini · 1 shared paper, 2017 · strength 0.06
- Rita Teresa Lawlor · 1 shared paper, 2017 · strength 0.06
- Roberto Salvia · 1 shared paper, 2017 · strength 0.06
- Cathy Quemener · 1 shared paper, 2016 · strength 0.04
- Anne Couvelard · 1 shared paper, 2016 · strength 0.04
- Vincent Castronovo · 1 shared paper, 2016 · strength 0.04
- Andréas Bikfalvi · 1 shared paper, 2016 · strength 0.04
- Núria Malats · 1 shared paper, 2015 · strength 0.04
- John P. Neoptolemos · 1 shared paper, 2015 · strength 0.04
- William Greenhalf · 1 shared paper, 2015 · strength 0.04
- Stephen P. Pereira · 1 shared paper, 2015 · strength 0.04
- Eithne Costello · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.